-
Single Cell Sequencing Service
-
High throughput sequencing services
-
Cell-based immune-related assays
-
Proteomics Testing Services
-
Small molecule metabolite detection services
Exome sequencing
Product Description
Case Analysis
Results Display
Sample Submission Guidelines
Q&A
Whole Exome Sequencing (WES) refers to the use of sequence capture technology to capture and enrich DNA from exome regions for high-throughput sequencing, which can directly identify genetic variants associated with protein function variation. Exome sequencing has been applied to the search for disease-causing and susceptibility genes associated with a variety of complex diseases.
technology roadmap
technical parameter
|
Sample requirements |
Sequencing strategy |
Lead time |
|
Sample type: genomic DNA Total sample concentration: ≥20 ng/μl (Qubit quantification) Total sample mass: ≥3.0 μg (total of 3 times of library building, excluding consuming of sample assay, Qubit quantification) Sample purity: OD260/280 =1.7~2.2 Electrophoresis requirements: clear main band, no degradation or mild degradation, no serious RNA or protein contamination. (latest electrophoresis result of the sample delivery date)
|
Sequencing type: Illumina/MGI PE150. Sequencing depth: germ cell mutations ≥ 100X (10G). Somatic mutations ≥150X (15G) |
45 days |
Product advantages
a. High specificity: Use mainstream kit, have stable capture efficiency, comprehensive exon region coverage and high capture specificity;
b. Cost-effective: comprehensive functional annotation of exon regions, which can effectively identify disease- or trait-related regions and save research costs;
c. High information efficiency: Compared with whole genome sequencing, it has deeper coverage and better data precision, less interference information and easy to analyse.
关注我们:
Message:
Tel:
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置: Wuhan Biobank
表单验证提示文本: The content cannot be empty!
循环体没有内容时: Sorry, no matching content was found.
CSS / JS 文件放置地
